Clinical Trials on Alopecia Universalis

Total 498 results

Biolab Sanus Farmaceutica

Not yet recruiting

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Telogen Effluvium
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women

Telogen Effluvium

France
Cooler Heads Care Inc.

Not yet recruiting

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Breast Cancer | Alopecia | Chemotherapy-induced Alopecia | Hair Loss
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Aderans Research Institute

Completed

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)

Androgenetic Alopecia | Male Pattern Baldness | Female Pattern Baldness

United States
Assiut University

Not yet recruiting

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Zagazig University

Recruiting

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Alopecia Areata

Egypt
NEXTGEN Bioscience

Not yet recruiting

Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Al-Azhar University

Not yet recruiting

Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata

Alopecia Areata

Egypt
AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom
Sohag University

Recruiting

Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Alopecia Areata

Egypt
Sohag University

Not yet recruiting

Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Montefiore Medical Center
Paxman

Recruiting

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Alopecia

United States
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Not yet recruiting

Treatment of Alopecia Using Follicular Stem Cells

Alopecia
Al-Azhar University

Recruiting

Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata (AA)

Alopecia Areata

Egypt
Tel-Aviv Sourasky Medical Center

Not yet recruiting

Fecal Transplant for Alopecia Areata

Alopecia Areata
Alexandria University

Not yet recruiting

Intralesional Vitamin D in Alopecia Areata

Alopecia Areata

Egypt
Dr. Peter C. Friedman

Completed

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Androgenetic Alopecia

United States
CorEvitas

Enrolling by invitation

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Alopecia Areata

United States
Amgen

Completed

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
University of California, Irvine

Completed

The Utility of Platelet Rich Plasma in Hair Loss

Androgenetic Alopecia

United States
University Hospitals Cleveland Medical Center

Terminated

Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai

Completed

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Momentum Data
Pfizer; University of Oxford

Active, not recruiting

Healthcare Disparities in Alopecia Areata

Alopecia Areata

United Kingdom
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Alopecia Areata

China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Israel, Japan, Argentina, Brazil
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.

Alopecia Areata

Pakistan
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Inventage Lab., Inc.

Completed

A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001

Androgenetic Alopecia

Australia
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Alopecia Areata

Alopecia Areata

China, Australia, United States
Janssen Research & Development, LLC

Withdrawn

A Study of JNJ-64304500 in Participants With Alopecia Areata

Alopecia Areata

United States, Japan, France, Australia
Alexandria University

Completed

Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Aclaris Therapeutics, Inc.

Terminated

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Alopecia Areata

United States
Kasr El Aini Hospital

Unknown

Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional Steroids

Alopecia Areata

Egypt
Centre Hospitalier Universitaire de Nice

Completed

TREg Activation in the Treatment of the PELADE (Alopecia Areata) (TreatPelade)

Alopecia Areata

France
Columbia University
Locks of Love; Alopecia Areata Initiative - Gates Foundation

Completed

Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata

Alopecia Areata

United States
GlaxoSmithKline

Completed

AVODART® Alopecia Post-marketing Surveillance (PMS) (AVODART®PMS)

Alopecia

Korea, Republic of
Elena Pope
Dermatology Foundation

Terminated

Topical Garlic Concentrate for Alopecia Areata in Children

Alopecia Areata

Canada
University of British Columbia

Completed

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

Alopecia Areata

Canada
Restoration Robotics, Inc.

Unknown

Computer-Assisted Hair Implantation Using ARTAS System VS Manual Implantation Technique Hair Restoration Study

Androgenic Alopecia

United States
University of Miami

Completed

Vytorin in the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Response of Topical Capsaicin in Alopecia Areata

Alopecia Areata

United States
Johnson & Johnson Healthcare Products Division...

Completed

Clinical Trial in Females With Female Pattern Hair Loss

Alopecia

United States, United Kingdom, Canada, France, Germany
Freedom Laser Therapy, Inc.
TKL Research, Inc.

Unknown

24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness

Androgenetic Alopecia

United States
Siriraj Hospital

Unknown

The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata

Alopecia Areata

Thailand
Restoration Robotics, Inc.

Completed

Computer-Assisted Versus Manual Hair Harvest Comparative Study

Androgenetic Alopecia

United States
Mitos Pharmaceuticals

Terminated

Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy

Alopecia
Egymedicalpedia

Recruiting

Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser

Alopecia Areata

Egypt
Q32 Bio Inc.
Innovaderm Research Inc.

Recruiting

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Alopecia Areata

United States
Venus Concept

Recruiting

Computer-Assisted Hair Restoration Study Using ARTAS System

Androgenic Alopecia

United States

3

Subscribe